TITLE:
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

CONDITION:
Carcinoma, Renal Cell

INTERVENTION:
ZD6126

SUMMARY:

      The purpose of this study is to assess the biological activity of ZD6126 in subjects with
      newly diagnosed metastatic renal cell carcinoma (stage IV).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Newly diagnosed metastatic renal cell carcinoma

          -  Suitable for nephrectomy

        Exclusion Criteria:

          -  Prior chemotherapy, biological therapy or radiation therapy for renal cell carcinoma
             or within the last 3 years for any other cancer

          -  Significant cardiac event within 3 months of entry

          -  Any history of coronary angioplasty or history of myocardial infarction
      
